Shield Therapeutics (LON:STX) Share Price Passes Below Fifty Day Moving Average – Here’s Why

Shield Therapeutics plc (LON:STX) shares crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 3.03 ($0.04) and traded as low as GBX 2.70 ($0.03). Shield Therapeutics shares last traded at GBX 2.80 ($0.04), with a volume of 416,748 shares traded.

Shield Therapeutics Trading Up 1.8 %

The company has a debt-to-equity ratio of 3,691.50, a quick ratio of 2.16 and a current ratio of 1.05. The company has a 50 day moving average of GBX 3.03 and a 200 day moving average of GBX 3.14. The stock has a market capitalization of £21.90 million, a price-to-earnings ratio of -70.00 and a beta of 1.42.

Shield Therapeutics Company Profile

Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.